Cargando…

CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer

BACKGROUND: Recently, we reported cytoskeleton-associated protein2 (CKAP2) as a possible new prognostic breast cancer marker. However, it has not yet been applied in clinic. Therefore, clinical significance of CKAP2 was evaluated in comparison with that of Ki-67 in a cohort of breast cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sim, Sung Hoon, Bae, Chang-Dae, Kwon, Youngmi, Hwang, Hai-Li, Poojan, Shiv, Hong, Hye-In, Kim, Kyungtae, Kang, Seo-Hee, Kim, Han-Seong, Um, Tae-Hyun, Park, In Hae, Lee, Keun Seok, Jung, So-Youn, Lee, Seeyoun, Kang, Han-Sung, Lee, Eun Sook, Kim, Mi-Kyung, Hong, Kyeong-Man, Ro, Jungsil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542386/ https://www.ncbi.nlm.nih.gov/pubmed/28771517 http://dx.doi.org/10.1371/journal.pone.0182107

Ejemplares similares

Chromatin CKAP2, a New Proliferation Marker, as Independent Prognostic Indicator in Breast Cancer
por: Kim, Han-Seong, et al.
Publicado: (2014)

The invasive lobular carcinoma as a prototype luminal A breast cancer: A retrospective cohort study
por: Jung, So-Youn, et al.
Publicado: (2010)

Locoregional Recurrence of Breast Conserving Surgery after Preoperative Chemotherapy in Korean Women with Locally Advanced Breast Cancer
por: Lee, Seeyoun, et al.
Publicado: (2011)

Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor–Positive and HER-2–Negative Breast Cancer with Neoadjuvant Chemotherapy
por: Lee, Eun-Gyeong, et al.
Publicado: (2023)

Clinicopathological Factors Associated with Oncotype DX Risk Group in Patients with ER+/HER2- Breast Cancer
por: Song, Ran, et al.
Publicado: (2023)

Clinical implications of proliferation activity in T1 or T2 male gastric cancer patients
por: Kim, Young-Woo, et al.
Publicado: (2015)

Breast Cancer–Related Lymphedema after Neoadjuvant Chemotherapy
por: Kim, Myungsoo, et al.
Publicado: (2015)

SARS-CoV-2 Spike protein promotes vWF secretion and thrombosis via endothelial cytoskeleton-associated protein 4 (CKAP4)
por: Li, Kan, et al.
Publicado: (2022)

Differences in clinical outcomes between HER2-negative and HER2-positive luminal B breast cancer
por: Kang, Byeongju, et al.
Publicado: (2023)

Determination of Protein Expression Level in Cultured Cells by Immunocytochemistry on Paraffin-embedded Cell Blocks
por: Poojan, Shiv, et al.
Publicado: (2018)

CKAP2 phosphorylation by CDK1/cyclinB1 is crucial for maintaining centrosome integrity
por: Yoo, Bum Ho, et al.
Publicado: (2017)

Criteria for identifying residual tumours after neoadjuvant chemotherapy of breast cancers: a magnetic resonance imaging study
por: Kim, Yunju, et al.
Publicado: (2021)

Association of Polymorphisms and Haplotypes in the Insulin-Like Growth Factor 1 Receptor (IGF1R) Gene with the Risk of Breast Cancer in Korean Women
por: Kang, Han-Sung, et al.
Publicado: (2014)

Antiproliferative factor (APF) binds specifically to sites within the cytoskeleton-associated protein 4 (CKAP4) extracellular domain
por: Chavda, Burzin, et al.
Publicado: (2017)

Effect of Time Interval between Breast-Conserving Surgery and Radiation Therapy on Outcomes of Node-Positive Breast Cancer Patients Treated with Adjuvant Doxorubicin/Cyclophosphamide Followed by Taxane
por: Koh, Hyeon Kang, et al.
Publicado: (2016)

BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy
por: Kim, Sung-Bae, et al.
Publicado: (2019)

LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis
por: Feng, Yanqing, et al.
Publicado: (2021)

CKAP2 Ensures Chromosomal Stability by Maintaining the Integrity of Microtubule Nucleation Sites
por: Case, Chanelle M., et al.
Publicado: (2013)

CKAP2L, as an Independent Risk Factor, Closely Related to the Prognosis of Glioma
por: Zhu, Li, et al.
Publicado: (2021)

Novel variants identified in CKAP2L in two siblings with Filippi syndrome
por: Patrick, Ryan J., et al.
Publicado: (2022)

The mitotic spindle protein CKAP2 potently increases formation and stability of microtubules
por: McAlear, Thomas S, et al.
Publicado: (2022)

CKAP2 overexpression correlates with worse overall survival in patients with lung adenocarcinoma
por: Zhang, Sen, et al.
Publicado: (2022)

Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study
por: Kim, Jeongseon, et al.
Publicado: (2009)

Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast Cancer
por: Kim, Tae Hyun, et al.
Publicado: (2021)

Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16)
por: Sim, Sung Hoon, et al.
Publicado: (2019)

Correlation of HER2, p95HER2 and HER3 Expression and Treatment Outcome of Lapatinib plus Capecitabine in her2-Positive Metastatic Breast Cancer
por: Han, Sae-Won, et al.
Publicado: (2012)

High EZH2 Protein Expression Is Associated with Poor Overall Survival in Patients with Luminal A Breast Cancer
por: Jang, Si-Hyong, et al.
Publicado: (2016)

Knockdown of CKAP2 Inhibits Proliferation, Migration, and Aggregate Formation in Aggressive Breast Cancer
por: dos Santos, Alexsandro, et al.
Publicado: (2022)

A Case of Locally Advanced Breast Cancer Complicated by Pulmonary Tumor Thrombotic Microangiopathy
por: Kim, Hak Jin, et al.
Publicado: (2012)

Potential antitumor effects of nitrogen-containing bisphosphonate in hormone receptor negative breast cancer patients with bone metastases
por: Park, In Hae, et al.
Publicado: (2009)

Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy
por: Kim, Hyunhee, et al.
Publicado: (2021)

Trends in Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy in Korean Carriers of the BRCA1/2 Mutation
por: Jung, Sung Mi, et al.
Publicado: (2020)

RNA-Binding Profiles of CKAP4 as an RNA-Binding Protein in Myocardial Tissues
por: Zhu, Hong, et al.
Publicado: (2021)

Prognostic significance of CKAP2L expression in patients with clear cell renal cell carcinoma
por: Liu, Zhi, et al.
Publicado: (2023)

Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: an open-label expanded access study in Korea
por: Ro, Jungsil, et al.
Publicado: (2012)

TAGLN2 regulates T cell activation by stabilizing the actin cytoskeleton at the immunological synapse
por: Na, Bo-Ra, et al.
Publicado: (2015)

Involvement of FAK-ERK2 signaling pathway in CKAP2-induced proliferation and motility in cervical carcinoma cell lines
por: Guo, Qi-sang, et al.
Publicado: (2017)

Up-regulation of CKAP2L expression promotes lung adenocarcinoma invasion and is associated with poor prognosis
por: Xiong, Guosheng, et al.
Publicado: (2019)

CKAP2L, a crucial target of miR-326, promotes prostate cancer progression
por: Li, Qi, et al.
Publicado: (2022)

Analysis of the Potent Prognostic Factors in Luminal-Type Breast Cancer
por: Kim, Han-Sung, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7kksd32b1bsufahe3t6rhdd1b1